Related Experiment Video
Updated: Jun 16, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Oxidative stress in multiple sclerosis]
Elzbieta Miller1, Małgorzata Mrowicka, Krystian Zołyński
1III Ogólny Szpital w Łodzi, Oddział Rehabilitacji. betty.miller@interia.pl
Abstract:
Accumulating data indicate that oxidative stress (OS) plays a major role in the pathogenesis of multiple sclerosis (MS). Reactive oxygen species (ROS), leading to OS, generated in excess primarily by macrophages, have been implicated as mediators of demyelization and axonal damage in MS. ROS cause damage to main cellular components such as lipids, proteins and nucleic acids (e.g., RNA, DNA), resulting in cell death by necrosis or apoptosis. In addition, weakened cellular antioxidant defense systems in the central nervous system (CNS) in MS, and its vulnerability to ROS effects may augmented damage. Thus, treatment with antioxidants might theoretically prevent propagation of tissue damage and improve both survival and neurological outcome. Central nervous system is particularly susceptible to ROS-induced damage due to the high oxygen demands of the brain and low concentration of endogenous antioxidants. Its refer both enzymatic antioxidants: catalase, glutathione peroxidase, glutathione reductase, superoxide dismutase and nonenzymatic antioxidants glutathione, vitamins A,C,D, coenzym Q, uric acid etc. Enzymatic and non enzymatic antioxidants like vitamins, micro and macro elements could regulate progress and function different immunologic cells. Modulation of immunologic processes by this components could be an effective method in decreased risk of incidence of disease and(or) treatment of MS or other immunologic diseases.
Insights
Oxidative stress from reactive oxygen species contributes to multiple sclerosis (MS) pathogenesis. Antioxidant therapies may protect against tissue damage and improve neurological outcomes in MS patients.
Area of Science:
- Neuroimmunology
- Oxidative Stress Research
Context:
- Multiple sclerosis (MS) pathogenesis involves significant oxidative stress (OS).
- Reactive oxygen species (ROS), primarily from macrophages, mediate demyelination and axonal damage in MS.
- The central nervous system (CNS) is vulnerable to ROS due to high oxygen demand and low antioxidant levels.
Purpose:
- To explore the role of oxidative stress in multiple sclerosis.
- To investigate the potential therapeutic benefits of antioxidants in MS treatment.
Summary:
- Excess ROS generated by macrophages cause cellular damage (lipids, proteins, nucleic acids), leading to cell death in MS.
- Compromised antioxidant defenses in the CNS exacerbate ROS-induced damage.
- Antioxidant treatments, including enzymatic and non-enzymatic compounds, show potential for managing MS and other immune diseases.
Impact:
- Antioxidant interventions could prevent further tissue damage in MS.
- Therapeutic strategies targeting ROS may improve patient survival and neurological function.
- Modulating immune cell function with antioxidants offers a potential approach for MS prevention and treatment.
